Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-1889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism ; day:17 ; month:8 ; year:2016 ; pages:1-8
Science China / Life sciences. Life sciences ; (17.8.2016), 1-8
- Urheber
-
Lu, Yong
- Beteiligte Personen und Organisationen
-
Lin, Hua
Zhai, Kan
Wang, Xiaojuan
Zhou, Qiong
Shi, Huanzhong
SpringerLink (Online service)
- DOI
-
10.1007/s11427-016-0097-y
- URN
-
urn:nbn:de:1111-201609146298
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lu, Yong
- Lin, Hua
- Zhai, Kan
- Wang, Xiaojuan
- Zhou, Qiong
- Shi, Huanzhong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Macrophage derived interleukin-10 promotes malignant pleural effusion formation
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
Malignant pleural effusion diagnosis and therapy
Malignant pleural effusion: current understanding and therapeutic approach
mRNA markers associated with malignant pleural effusion
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion
Diagnostic value of medical thoracoscopy in malignant pleural effusion
Closed Pleural Biopsy is Still Useful in the Evaluation of Malignant Pleural Effusion
Chemical pleurodesis for malignant pleural effusion: which agent is perfect?
Circulating biomarkers of malignant pleural effusion deriving from extrapulmonary tumours
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
Macrophage derived interleukin-10 promotes malignant pleural effusion formation
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
Malignant pleural effusion diagnosis and therapy
Malignant pleural effusion: current understanding and therapeutic approach
mRNA markers associated with malignant pleural effusion
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion
Diagnostic value of medical thoracoscopy in malignant pleural effusion
Closed Pleural Biopsy is Still Useful in the Evaluation of Malignant Pleural Effusion
Chemical pleurodesis for malignant pleural effusion: which agent is perfect?
Circulating biomarkers of malignant pleural effusion deriving from extrapulmonary tumours
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
Macrophage derived interleukin-10 promotes malignant pleural effusion formation
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
Malignant pleural effusion diagnosis and therapy
Malignant pleural effusion: current understanding and therapeutic approach
mRNA markers associated with malignant pleural effusion
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion
Diagnostic value of medical thoracoscopy in malignant pleural effusion
Closed Pleural Biopsy is Still Useful in the Evaluation of Malignant Pleural Effusion
Chemical pleurodesis for malignant pleural effusion: which agent is perfect?
Circulating biomarkers of malignant pleural effusion deriving from extrapulmonary tumours